Cancer chemotherapy in the older cancer patient

Urologic Oncology: Seminars and Original Investigations

Volumn 27, Issue 6, 2009, Pages 633-642

  Carreca, Ignazio ^a   Balducci, Lodovico ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Cancer; Chemotherapy; Elderly; Systemic treatment

Indexed keywords

ALKALOID DERIVATIVE; ANTHRACYCLINE; BLEOMYCIN; CAPECITABINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DAUNORUBICINOL; DOXORUBICIN; FLOXURIDINE; FLUOROURACIL; IDARUBICINOL; METHOTREXATE; PLATINUM DERIVATIVE; PREDNISONE; PROTEIN TYROSINE KINASE INHIBITOR; RAZOXANE; TAXANE DERIVATIVE; TRASTUZUMAB; VINCRISTINE SULFATE;

CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CARDIOMYOPATHY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; FRAIL ELDERLY; GERIATRIC CARE; HUMAN; KIDNEY FUNCTION; LARGE CELL LYMPHOMA; MUCOSA INFLAMMATION; MYOCARDIAL DISEASE; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AGING; ANTINEOPLASTIC AGENTS; GERIATRIC ASSESSMENT; HUMANS; KIDNEY; LIFE EXPECTANCY; MEDICAL ONCOLOGY; NEOPLASMS; PATIENT CARE PLANNING; TREATMENT OUTCOME;

EID: 70350494962     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.08.006     Document Type: Review

References (58)

1. Balducci L., and Ershler W.B. Cancer and aging: A nexus at several levels. Nat Rev Cancer 5 (2005) 655-662
2. Duthie E. Physiology of age: Relevance to symptoms, perceptions, and treatment tolerance. In: Balducci L., Lyman G.H., Ershler W.B., et al. (Eds). Comprehensive Geriatric Oncology (2004), Taylor and Francis, London 207-223
3. Balducci L. Cancer chemotherapy in the older person. In: Balducci L., Ershler B., and DeGaetano G. (Eds). Blood disorders in the elderly (2008), University Press, Cambridge 225-236
4. Walston J., Hadley E.C., Ferrucci L., et al. Research agenda for frailty in older adults: Toward a better understanding of physiology and etiology. Summary of the proceedings of the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults, Jun 2006. J Am Geriatr Soc 54 (2006) 991-1001
5. Ferrucci L., Corsi A., Lauretani F., et al. The origin of age-related pro-inflammatory state. Blood 105 (2005) 2294-2299
6. Jenny N.S., Yanez N.D., Psaty B.M., et al. Inflammation biomarkers and near-term death in older men. Am J Epidemiol 165 (2007) 684-695
7. Cohen H.J., Harris T., and Pieper C.F. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med 114 (2003) 180-187
8. Störk S., Feelders R.A., van der Beld A.W., et al. Prediction of mortality risk in the elderly. Am J Med 119 (2006) 519-525
9. Carey E.C., Covinsky K.E., Lui L.Y., et al. Prediction of mortality in community-living frail elderly people with long-term care needs. J Am Geriatr Soc 56 (2008) 68-75
10. Lee S.J., Lindquist K., Segal M.R., et al. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 295 (2006) 801-808
11. Extermann M., Chen A., Cantor A.B., et al. Predictors of tolerance of chemotherapy in older patients. Eur J Cancer 38 (2002) 1466-1473
12. Meyerhardt J.A., Tepper J.E., Niedzwiecki D., et al. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: Findings from Intergroup Trial 0114. J Clin Oncol 22 (2004) 648-657
13. Balducci L., and Ferrucci L. Anemia of aging and cancer. Semin Hematol 45 (2008) 243-249
14. Rizzo J.D., Somerfield M.R., Hagerty K.L., et al. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol 26 (2008) 132-149
15. Bohlius J., Wilson J., Seidenfeld J., et al. Recombinant human erythropoietins and cancer patients: Updated meta-analysis of 57 studies including 9,353 patients. J Natl Cancer Inst 98 (2006) 708-714 [Review]
16. Bennett C.L., Silver S.M., Djulbegovic B., et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration in the treatment of cancer associated anemia. JAMA 299 (2008) 914-924
17. Aapro M., Leonard R.C., Barnadas A., et al. Effect of once-weekly epoetin β on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: Results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study. J Clin Oncol 26 (2008) 592-598
18. Inouye S.K., Studenski B., Timetti M.E., et al. Geriatric syndromes: Clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc 55 (2007) 780-791 [Review]
19. Tinetti M.E., Gordon C., Sogolow E., et al. Fall-risk evaluation and management: Challenges in adopting geriatric care practices. Gerontologist 46 (2006) 717-725
20. Ethgen O., Gillain D., Gillet P., et al. Age- and sex-stratified prevalence of physical disabilities and handicap in the general population. Aging Clin Exp Res 16 (2004) 389-397
21. Haley W.E., Burton A.M., Lamonde L.A., et al. Family caregiving issues for older cancer patients. In: Balducci L., Lyman G.H., Ershler W.B., et al. (Eds). Comprehensive Geriatric Oncology (2004), Taylor and Francis, London 843-853
22. Haijar E.R., Cafiero A.C., and Hanlon J.T. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 5 (2007) 345-351
23. Rahman A., Pazdur R., Wang Y., et al. The value meal: Effect of food on lapatinib bioavailability. J Clin Oncol 25 (2007) 5333-5334
24. Balducci L., Cohen H.J., Engtrom P., et al. Senior adult oncology clinical practice guidelines in oncology. J Natl Compr Network 3 (2005) 572-590
25. Fried L.P., Tangen C.M., Wakston J., et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56 (2001) M146-M156
26. Anonymous. Assessing care of vulnerable elders. 3. Quality indicators. J Am Ger Soc 55 Suppl 2 (2007) 464-487
27. Katz S., Branch L.B., Branson M.H., et al. Active life expectancy. N Engl J Med 309 (1983) 1218-1224
28. Jagger C., Matthews R., Matthews F., et al. The burden of diseases on disability-free life expectancy in later life. J Gerontol A Biol Sci Med Sci 62 (2007) 408-414
29. Pinder M., Duan Z., Goodwin J.S., et al. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 25 (2007) 3808-3815 [Epub 2007 Jul]
30. Tralongo P., Respini D., and Ferrau S. Fatigue and aging. Crit Rev Oncol Hematol 48 Suppl (2003) 57-64
31. Luciani A., Balducci L., Extermann M., et al. Fatigue may be a cause of functional dependence in older cancer patients. Am J Clin Oncol 31 (2008) 424-430
32. Balducci L., and Hardy C.L. Hemopoietic reserve and aging. In: Balducci L., Ershler W.B., and DeGaetano G. (Eds). Blood disorders in the elderly (2008), Cambridge University press, Cambridge 120-129
33. Chrischilles E.A., Link B.K., Scott L.D., et al. Factors associated with early termination of CHOP therapy and the impact on survival among patients with chemosensitive intermediate grade non-Hodgkin's lymphoma. Cancer Control 10 (2003) 396-403
34. Balducci L. Cancer chemotherapy in the older person. In: Balducci L., Ershler W.B., and DeGaetano G. (Eds). Blood disorders in the elderly (2008), Cambridge University Press, Cambridge 225-236
35. Schrijvers D., Highley M., DeBruyn E., et al. Role of red blood cells in pharmacokinetics of chemotherapeutic agents. Anticancer Drugs 10 (1999) 147-153
36. Marx G.M., Blake G.M., Galani E., et al. Evaluation of the Cockroft-Gault, Jelliffe, and Wright formulas in estimating renal function in elderly cancer patients. Ann Oncol 15 (2004) 291-295
37. Melchert M., and Lancet J. Acute myeloid leukemia in the elderly. In: Balducci L., Erhsler W.B., and DeGaetano G. (Eds). Blood disorders in the elderly (2008), Cambridge University Press, Cambridge 237-255
38. Vitolo U., Ferreri A.J., and Montoto S. Follicular lymphomas. Crit Rev Oncol Hematol 66 (2008) 248-261
39. Campisi J. Hot topics aging and cancer. Cell Biol. Aging Cell 7 (2008) 281-284
40. Alekshun T.J., and Alsina M. Multiple myeloma. In: Balducci L., Erhsler W.B., and DeGaetano G. (Eds). Blood disorders in the elderly (2008), Cambridge University Press, Cambridge 272-289
41. Daidone M.G., Coradini D., Martelli G., et al. Primary breast cancer in elderly women: Biological profile and relation with clinical outcome. Crit Rev Oncol Hematol 45 (2003) 313-325
42. Kuderer N.M., Dale D.C., Crawford J., et al. Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: A systematic review. J Clin Oncol 25 (2007) 3158-3167
43. Shayne M., Culakova E., Poniewierski M.S., et al. Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy. Cancer 110 (2007) 1611-1620
44. Smith T.J., Katcheressian J., Lyman G.H., et al. 2006 Update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline. J Clin Oncol 24 (2006) 3187-3205
45. Sonis S.T. Pathobiology of oral mucositis: Novel insights and opportunities. J Support Oncol 5 Suppl 4 (2007) 3-11
46. Worthington H.V., Clarckson J.E., and Eden O.B. Pathobiology of oral mucositis: Novel insights and opportunities. J Support Oncol 5 Suppl 4 (2007) 3-11
47. Rosen L.S., Abdi E., Davis I.D., et al. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. J Clin Oncol 24 (2006) 5194-5200
48. Floyd J.D., Nguyen D.T., Lobins R.L., et al. Cardiotoxicity of cancer therapy. J Clin Oncol 23 (2005) 7685-7696 [Review]
49. Walker M., and Ni O. Neuroprotection during chemotherapy: A systematic review. Am J Clin Oncol 30 (2007) 82-92
50. Schaapveld M., Visser O., Lowman M.J., et al. Risk of new primary non-breast cancers after breast cancer treatment: A Dutch population-based study. J Clin Oncol 26 (2008) 1239-1246
51. Muss H.B., Berry D.A., Cirrincione C., et al. Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: The Cancer and Leukemia Group B Experience. J Clin Oncol 25 (2007) 3699-3704
52. Patt D.A., Duan Z., Fang S., et al. Acute myeloid leukemia after adjuvant breast cancer therapy in older women: Understanding risk. J Clin Oncol 25 (2007) 3871-3876
53. Hershman D., Neugut A.I., Jacobson J.S., et al. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst 99 (2007) 196-205
54. Balducci L., Al Halawani H., Charu V., et al. Elderly cancer patients receiving chemotherapy benefit from first-cycle pegfilgrastim. Oncologist 12 (2007) 1416-1424
55. Chlebowski R.T. Translating trial data into patients benefits: Making the right choice. Breast 17 Suppl 3 (2008) 9-15
56. Holzberlein J.M., Castle E.P., and Thrasher J.B. Complications of androgen-deprivation therapy for prostate cancer. Clin Prostate Cancer 2 (2003) 147-152
57. Balducci L. Molecular insight in cancer treatment and prevention. Int J Biochem Cell Biol 39 (2007) 1329-1336
58. Balducci L., Tam-MacDewitt J., Hauser R., et al. Long overdue: Phase II studies in older cancer patients. Where does the FDA stand?. J Clin Oncol 26 (2008) 1387-1388